MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Omega Diagnostics welcomes Abingdon Health's update on future use of AbC-19 rapid test

StockMarketWire.com

Medical diagnostics company Omega Diagnostics said Abingdon Health had confirmed that they continue to work constructively with the Medicines and Healthcare products Regulatory Agency to try to enable approval for home use and self-test of the AbC-19TM Rapid Test in the UK.

Abingdon also confirmed that wile the DHSC continued to have first refusal for supplies of the AbC-19 rapid test, the UK-RTC is liaising with customers and regulatory authorities across a total of 27 international territories, to allow future use of the product outside of the UK.





At 9:50am: (LON:ODX) Omega Diagnostics Group PLC share price was 0p at 56p



Story provided by StockMarketWire.com